Status Epilepticus: an Overview for Neuroscientists

被引:0
作者
Raina, Neha [1 ]
Yadav, Monu [2 ]
Rani, Radha [1 ]
Ojha, Brijesh [1 ]
Bhardwaj, Bigul Yogeshver [3 ]
Gupta, Madhu [1 ]
机构
[1] Delhi Pharmaceut Sci & Res Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Sec 3,MB Rd, New Delhi 110017, India
[2] GD Goenka Univ, Sch Med & Allied Sci, Dept Pharm, Gurgaon 122103, India
[3] Kurukshetra Univ, Inst Pharmaceut Sci, Kurukshetra, Haryana, India
关键词
Status epilepticus; GABA; Seizures; Neurological disorders; Glutamate receptors; Antiepileptic drugs; REFRACTORY STATUS EPILEPTICUS; CONVULSIVE STATUS EPILEPTICUS; GAMMA-AMINOBUTYRIC-ACID; BLOOD-BRAIN-BARRIER; SEIZURE IDENTIFICATION; QUANTITATIVE EEG; EPILEPSY; ALLOPREGNANOLONE; MANAGEMENT; RECEPTORS;
D O I
10.1007/s40495-021-00272-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent FindingsEvidences suggest the pathophysiological role of GABA, glutamate, inflammatory cascade, hypoxia, etc. in the development of status epilepticus (SE). But the exact understanding of SE seizure is still unknown.Purpose of ReviewSE is a lethal neurological disorder that is associated with elevated rates of mortality and morbidity. SE is demarcated by recurring seizures caused by a failure of mechanisms responsible for the termination of seizures or from the initiation of mechanisms, which lead to abnormally, persistent seizures after time point (t1). Long-term consequences are spotted in this condition after time point (t2), together with the death of neurons, neuronal injury, and alteration of neuronal networks, depending on the type and duration of seizures. Clinically first-line treatment with benzodiazepines is given for seizure inhibition. But in severe cases, these drugs are not efficient for treatment. The unavailability of viable medications to halt the onset and progression of the condition could be due to a lack of understanding of the pathophysiological mechanism. Due to the complexity of the brain, it is very difficult to understand exact pathways; thorough understanding of pathophysiology would be beneficial in designing new drug regimen for patients.SummaryThis review paper emphasizes on pathophysiology, etiology, diagnostic parameters, and drugs used in the secession of seizures promptly, which would be helpful for the development of effective therapeutics.
引用
收藏
页码:36 / 47
页数:12
相关论文
共 109 条
  • [1] Neurocritical Care: Status Epilepticus Review
    Al-Mufti, Fawaz
    Claassen, Jan
    [J]. CRITICAL CARE CLINICS, 2014, 30 (04) : 751 - +
  • [2] An Insight into the Current Understanding of Status Epilepticus: From Concept to Management
    Al-Sofyani, Khouloud Abdulrhman
    [J]. NEUROLOGY RESEARCH INTERNATIONAL, 2021, 2021
  • [3] Novel drugs and early polypharmacotherapy in status epilepticus
    Amengual-Gual, Marta
    Sanchez Fernandez, Ivan
    Wainwright, Mark S.
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 68 : 79 - 88
  • [4] [Anonymous], 2020, Seizure Rescue Medication: Caregiver Education in a Simulation Setting
  • [5] [Anonymous], 2020, ClinicalTrials.gov Identifier: NCT03115489
  • [6] [Anonymous], 2020, Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus (SRSE)
  • [7] [Anonymous], 2019, EEG Cap for Identification of Non-Convulsive Status Epilepticus
  • [8] Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus
    Bankstahl, Jens P.
    Loescher, Wolfgang
    [J]. EPILEPSY RESEARCH, 2008, 82 (01) : 70 - 85
  • [9] Baraban SC, 2020, Compounds and methods for treating an epileptic disorder, Patent No. [US10695325B2, 10695325]
  • [10] Drug-induced EEG pattern predicts effectiveness of ketamine in treating refractory status epilepticus
    Basha, Maysaa M.
    Alqallaf, Abdulradha
    Shah, Aashit K.
    [J]. EPILEPSIA, 2015, 56 (04) : E44 - E48